Owlet (OWLT) Competitors

Owlet (NYSE:OWLT) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap measuring and control equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

Which has better earnings & valuation, OWLT or CTKB?

Cytek Biosciences has higher revenue and earnings than Owlet. Cytek Biosciences is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$78.10M	1.57	-$12.54M	-$3.50	-2.06
Cytek Biosciences	$200.45M	2.60	-$6.02M	-$0.05	-81.90

Does the media refer more to OWLT or CTKB?

In the previous week, Cytek Biosciences had 3 more articles in the media than Owlet. MarketBeat recorded 4 mentions for Cytek Biosciences and 1 mentions for Owlet. Cytek Biosciences' average media sentiment score of 0.90 beat Owlet's score of 0.25 indicating that Cytek Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Owlet	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cytek Biosciences	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is OWLT or CTKB more profitable?

Cytek Biosciences has a net margin of -3.27% compared to Owlet's net margin of -54.45%. Owlet's return on equity of -0.36% beat Cytek Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-54.45%	-0.36%	-3.26%
Cytek Biosciences	-3.27%	-1.66%	-1.30%

Do institutionals and insiders have more ownership in OWLT or CTKB?

72.6% of Owlet shares are held by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are held by institutional investors. 67.1% of Owlet shares are held by company insiders. Comparatively, 10.3% of Cytek Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Do analysts recommend OWLT or CTKB?

Owlet currently has a consensus price target of $10.25, indicating a potential upside of 42.26%. Cytek Biosciences has a consensus price target of $5.60, indicating a potential upside of 36.75%. Given Owlet's stronger consensus rating and higher possible upside, equities analysts plainly believe Owlet is more favorable than Cytek Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Which has more volatility and risk, OWLT or CTKB?

Owlet has a beta of 1.8, meaning that its stock price is 80% more volatile than the S&P 500. Comparatively, Cytek Biosciences has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500.

Summary

Owlet and Cytek Biosciences tied by winning 8 of the 16 factors compared between the two stocks.